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Maturation Pathway in Bone Marrow Cell Development
PHSC populations purified to date (1) durably reconsti-
tute blood cells of all lineages when transplanted into
lethally irradiated mouse recipients (long-term reconsti-
tuting cells [LTRC]), (2) confer 30 day radioprotection
or short-term reconstituting cell (STRC) activity when
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²Laboratory of Leukocyte Biology transplanted in vivo, (3) give rise to CFU-s after 12 days
when transplanted into lethally irradiated mice, and (4)NCI-Frederick Cancer Research and
Development Center show little or no proliferative response to single hemato-
poietic growth factors (HGFs) but proliferate maximallyFrederick, Maryland 71702
to multiple HGF combinations that always include steel
factor (SLF). Furthermore, in those studies where in-
creasing numbers of purified PHSCs were transplanted
Summary into irradiated recipients in the absence of supporting
bone marrow, the STRC and CFU-s d12 activities could
While the majority of purified pluripotential hematopoi- not be completely separated from LTRC activity (Ploe-
etic stem cells (PHSC) express c-Kit, the receptor for macher and Brons, 1989; Wolf et al., 1993).
steel factor, we have phenotypically and functionally PHSCs are also unified by the expression of c-Kit
separated a distinct class of PHSC that does not ex- regardless of the methods used to purify these cells
press c-Kit. In contrast to c-Kit-postive (c-Kitpos) PHSC, (Ogawa et al., 1991; Okada et al., 1991, 1993; Orlic et
the c-Kit-negative (c-Kitneg) PHSC do not proliferate in al., 1993; Chung and Johnson, 1995). The importance
response to multiple hematopoietic growth factors in of SLF and c-Kit (SLF/c-Kit axis) to definitive hematopoi-
vitro and do not radioprotect or form macroscopic esis is highlighted by observations that the most severe
spleen colonies (CFU-s) when transplanted into le- deletions or mutations in either murine c-Kit (W locus)
thally irradiated recipients. However, the c-Kitneg PHSC or SLF (steel locus), which knock out gene function,
show delayed or slow reconstitution kinetics when result in prenatal lethality at roughly 13±15 days gesta-
cotransplanted with radioprotective bone marrow cells. tion due to the interruption of fetal liver hematopoiesis,
c-Kitneg PHSCs cells can give rise to c-Kitpos cells with while other organ systems develop normally (Russell,
CFU-s activity, radioprotective activity, and PHSC ac- 1979; Silvers, 1979) (mutations in the W or steel locus
tivity. Thus, constituitive hematopoiesis is maintained that do not ablate gene function are not lethal at this
by c-Kitpos PHSCS cells that are recruited from a more gestational age). Furthermore, antibodies that recognize
primitive quiescent c-Kitneg PHSC population, which c-Kit and block SLF binding abrogate hematopoietic
represents a critical developmental stage in definitive development in vitro and in vivo that is reversed by
hematopoiesis. removal of antibodies (Ogawa et al., 1991, 1993; Okada
et al., 1991). Taken together, the SLF/c-Kit axis supports
a critical developmental stage in hematopoietic cell
Introduction growth, and expression of c-Kit is required to maintain
steady state hematopoiesis by PHSCs. Therefore, we
The very rare pluripotential hematopoietic stem cell hypothesized that recruitment of c-Kitneg cells into this
(PHSC) population has been isolated and purified by a actively contributing pool of c-Kitpos PHSCs might be an
number of laboratories based on cell surface antigen important requirement to sustain definitive hematopoie-
expression, vital dye staining, cell size, and density sis. In this regard, we sought to establish the existence
(Spangrude et al., 1991; Bodine and Orlic, 1995; Scott of more primitive PHSCs that lack the expression of c-
and Gordon, 1995). As would be predicted, using combi- Kit and determine if the c-Kitpos PHSCs are recruited
nations of the above, many apparently phenotypically from a c-Kitneg population.
distinct PHSC cell populations have been purified, in-
cluding, for example, cells that coexpress Thy-1 and
ResultsSca-1 antigens (Thy-11Sca-11), combined with the lack
of antigens expressed on mature cell types (lineage-
Purification of c-Kitneg Bone Marrow Cellslow [Linlo) and PHSCs that bind weakly to wheat germ
by Counter Current Elutriationagglutinin and rhodamine (WGAloRhd123lo) (Visser et al.,
and Flow Cytometry1984, 1988; Muller-Sieburg et al., 1986; Ploemacher and
Because PHSCs are small lymphoblast-like cells withBrons, 1988a; Spangrude et al., 1988; Phillips et al.,
little or no signs of morphological differentiation, we1992; Bertoncello et al., 1985). However, while the phe-
chose to first fractionate bone marrow cells (BMCs)notype of purified PHSCs can differ greatly between
based on size using counter current centrifugal elutria-laboratories, all are unified by the expression of c-Kit
tion (CCE) at a flow rate of 25 ml/min (CCE-25), usingand by similar function in vivo and in vitro. For example,
previously described procedures (Ploemacher and Brons,
1988b; Jones et al., 1990). In agreement with the previ-
ous studies, we recovered 10%±20% of the starting³ To whom correspondence should be addressed (e-mail: kellerj@
mail.ncifcrf.gov). unfractionated BMC population at this flow rate and
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Figure 1. Purification and Characterization of CCE-25 Cells
(A) Purification of CCE-25 cells by flow cytometry. CCE-25 cells were labeled with flourescein (FITC)-conjugated anti-c-Kit monoclonal
antibodies and separated according to the proceedures outlined in the Experimental Procedures. Forward and side scatter properties of CCE-
25 cells and gate window (R1) set for sorting (upper left). Anti-c-Kit-FITC-stained CCE-25 cells and the gate windows (R3, c-Kitpos;R2, c-Kitneg)
set for sorting (upper right). Isotype-matched control antibody staining was used to determine gate settings (data not shown). Reanalysis of
CCE-25 c-Kitpos (lower right) and CCE-25 c-Kitneg (lower left) FACS-sorted cells, respectively.
(B) Expression of c-kit mRNA in fractionated CCE-25 cells by RT±PCR. Total RNA was isolated from CCE-25 c-Kitpos and CCE-25 c-Kitneg
sorted cells and then amplified by RT±PCR with primers specific for c-kit (upper panel) and b-actin (lower panel) according to the procedures
described in the Experimental Procedures. The c-kit primers amplified a 225 bp product corresponding to spliced c-kit RNA, while the b-actin
primers amplified a 323 bp product corresponding to b-actin DNA and a 275 bp product corresponding to spliced b-actin RNA. Reverse
transcriptase negative reactions were included as a control.
(C) The effect of hematopoietic growth factors on the proliferation of CCE-25 separated cells in soft agar colony assays. CCE225 and CCE-
25 c-Kitpos and CCE-25 c-Kitneg separated BMC were plated in soft agar colony assays in triplicate at the indicated cell densities and were
scored for colony growth after 7±10 days, as described in the Experimental Procedures. Cultures were supplemented with mIL-3 (30 ng/ml)
and mSLF (100 ng/ml) or multi-HGFs that included M-CSF, G-CSF, GM-CSF, EPO, IL-1, IL-6, LIF, IL-11, and FLT-3. Occasionally, a colony
was observed in plates that contained cell numbers greater than 2 3 105 CCE-25 c-Kitneg cells.
found that they were .98% small lymphocyte-like cells upon reanalysis (Figure 1A, lower right). To determine
whether the CCE-25 c-Kitneg sorted cells also lackedas demonstrated by the forward and side light scattering
profiles using flow cytometry (Figure 1A) and Giemsa c-kit RNA, total RNA was extracted from the CCE-25
c-Kitpos and CCE-25 c-Kitneg cells and then analyzed bystaining of cytocentrifuge preparations (data not shown).
To determine whether the CCE-25 cells expressed c-Kit, RT±PCR. c-kit RNA was not detected in the CCE-25-c-
Kitneg purified cell population by RT±PCR, even whenthe CCE-25 cells were labeled with antibodies that rec-
ognize c-Kit and analyzed by flow cytometry. Roughly amplifying large amounts (570 ngs) of mRNA (Figure 1B).
In comparison, a 225 bp fragment specific for c-kit RNA10% of the CCE-25 cells express c-Kit (both dull and
bright expression) (Figure 1A). The CCE-25 cells were was amplified from RNA obtained from both CCE-25-c-
Kitpos cell populations (Figure 1B) and the unfractionatedthen further purified by FACS sorting into CCE-25 c-Kitneg
(Figure 1A, region 2, R2) and CCE-25 c-Kitpos (Figure 1A, CCE-25 cells (data not shown). CCE-25-c-Kitneg RNA
loading controls were confirmed by amplifying actinregion 3, R3) cell populations using cell sorting gates
set to maximize cell separation (30%±40% of the CCE- RNA by RT±PCR. To better define the sensitivity of this
assay, we combined hematopoietic progenitor cell lines25 cell population was excluded). Reanalysis of the FACS-
sorted cells shows that no detectable c-Kitpos cells were that express c-Kit with cell lines that lack c-Kit expres-
sion in different ratios, extracted RNA, and determinedin the CCE-25 c-Kitneg sorted fraction (Figure 1A, lower
left), while the c-Kitpos cells contained some c-Kitneg cells that we could readily detect 1 c-Kitpos cell in 10,000
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of the surviving animals 4±6 months after transplantationTable 1. STRC and LTRC Activity of CCE-25 c-Kitpos and CCE-
demonstrated the presence of donor-derived B cells, Tc-Kitneg FACS-Separated Cells
cells, and granulocytes, indicating the presence of
LTRC (4±6 Months) LTRCs with trilineage reconstitution potential in theNumber STRC % Donor Cells
Cell of Cells 40±60 Day CCE-25 and normal bone marrow cell populations (Table
Fractions Injected Survival Gran. B Cell T Cell 1). In comparison, the CCE-25 c-Kitpos cells were greatly
enriched for and contained most, if not all, of the STRCNormal BMCs 2 3 105 5/5 93 6 4 83 6 7 .99
Saline None 0/10 Ð Ð Ð activity and LTRC activity detected in the total CCE-25
CCE-25 1 3 105 0/10 Ð Ð Ð cell population when transplanted with 10-fold fewer
CCE-25 2 3 105 9/10 95 6 3 91 6 4 .99 cells (2.5 3 104). The CCE-25 c-Kitneg cells did not pro-
CCE-25-Kitpos 2.5 3 104 9/10 95 6 2 .99 .99 mote the survival of the irradiated recipients and did not
CCE-25-Kitneg 5 3 106 0/10 Ð Ð Ð
contain STRC's even when transplanting up to 5 3 1061 3 106 0/10 Ð Ð Ð
cells (Table 1).5 3 105 0/10 Ð Ð Ð
Because the CCE-25 c-Kitneg cells did not promote
Donor-derived (Ly-5.2) CCE-25 BMCs and cells further purified by the short-term survival of transplanted mice, it was still
flow cytometry based on the expression of c-Kit were transplanted
possible that this population contained cells with onlyinto lethally irradiated host (Ly-5.1) mice and monitored for STRC
LTRC activity. To test this, decreasing numbers of donor-and LTRC activity according to the procedures outlined in the Exper-
derived CCE-25 c-Kitneg cells were cotransplanted withimental Procedures. These results are representative of two sepa-
rate experiments. 2 3 105 host-derived BMCs, which by themselves pro-
vide radioprotection in competitive repopulation assays
and promote the long-term survival of the transplanted
recipients (Figure 2A). Analysis of transplanted recipi-c-Kitneg cells by RT±PCR (data not shown). Furthermore,
ents in three experiments found that mice transplanteda positive signal for c-kit RNA can be detected following
with as few as 2.5 3 104 showed significant trilineageRT±PCR on as little as 1 ng of RNA from CCE-25 c-Kitpos
donor reconstitution only after 10±12 months (Figurescells. Thus, because CCE-25 c-Kitneg cells showed no
2A and 2B). The data presented in Figure 2A is thec-kit RNA expression by RT±PCR, this population was
average percent donor granulocyte, B cell, and T cellfurther examined for hematopoietic activity.
reconstitution in transplanted mice obtained from the
FACS analysis data for individual mice within a group.CCE-25 c-Kitneg Cells Represent a Unique
The FACS analysis for an individual mouse transplantedPHSC Population
with 5 3 104 CCE-25 c-Kitneg cells is illustrated in FigureSince it is known that purified PHSCs maximally prolifer-
2B, which shows donor granulocyte reconstitution inate in response to combinations of HGFs, we compared
the bone marrow (Ly-5.21GR-11), donor B cell reconsti-the ability of the c-Kit FACS-separated CCE-25 cells
tution in the bone marrow (Ly-5.21B2201), and donor Tto proliferate in soft agar. In agreement with previous
cell reconstitution in the thymus (Ly-5.21Thy-11); iso-results, the CCE-25 cell population proliferates weakly
type-matched controls are shown for comparison. All
in response to single HGFs (Figure 1C) (Jones et al.,
of the surviving recipient mice transplanted with 1 3 105
1990). However, in addition to what was previously ob-
or 5 3 104 CCE-25 c-Kitneg cells in competitive repopula-
served, the CCE-25 cells also contain progenitor cells tion assays showed donor cell reconstitution 10±12
that maximally proliferate in response to multiple HGFs months after transplantation. Also, the majority of mice
(e.g., IL-3/SLF or multiple combinations of HGFs) (Figure transplanted with 2.5 3 104 CCE-25 c-Kitneg cells (7 out
1C). Furthermore, .95% of the progenitor cells that pro- of 10 mice) showed donor reconstitution 10±12 months
liferate in response to multiple combinations of HGFs are after transplantation. No donor reconstitution was ob-
recovered in the CCE-25 c-Kitpos population, but these served 4 or 8 months after transplantation (LTRC activity
progenitors are absent in the CCE-25 c-Kitneg population is typically observed and measured 4±6 months after
even when plating these cells at densities two logs transplantion). The delayed reconstitution potential of
greater than the CCE-25 c-Kitpos cells. Thus, the majority the CCE-25 c-Kitneg cell population was observed in three
of progenitors that proliferate in response to multiple separate experiments. In comparison, CCE-25 c-Kitpos
HGFs are contained within the CCE-25 c-Kitpos cell frac- cells showed the expected kinetics of donor reconstitu-
tion. We have been unable to promote the proliferation tion (beginning 4±6 months after transplantation) in com-
of CCE-25 c-Kitneg cells in vitro using multiple cytokine petitive repopulation assays (Table 1; data not shown).
combinations (up to 12). Taken together, within the small cell fraction of normal
To determine whether the CCE-25 cell fractions con- bone marrow (CCE-25), the CCE-25 c-Kitpos cells pos-
tained radioprotective or STRC activity and LTRC or sess all of the activities previously ascribed to known
PHSC activity, cells were transplanted into mouse purified PHSC populations that include proliferative re-
strains that are congenic with respect to the expression sponse to multiple HGFs in vitro, STRC activity, and
of Ly-5 (CD-45), such that the extent of donor (Ly-5.2) LTRC activity, the hallmark of PHSCs. In contrast, PHSC
and host (Ly-5.1) cell reconstitution can be measured. activity in the CCE-25 c-Kitneg cells were only detected
While transplantation of 1 3 105 or fewer CCE-25 cells in LTRC assays with a unique delayed engraftment phe-
was insufficient to radioprotect lethally irradiated recipi- notype.
ents, transplantation of 2 3 105 donor-derived CCE-25
cells was sufficient to radioprotect mice for 40±60 days CCE-25 c-Kitneg Cells Have Pre-CFU-s Activity
(2 3 105 unfractionated BM were also sufficient to ra- Because CCE-25 c-Kitneg PHSCs show delayed engraft-
ment kinetics, efforts to further characterize and purifydioprotect these recipients) (Table 1). Further, analysis
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Figure 2. Competitive Repopulation Assays
(A) Long-term reconstituting cell activity of
CCE-25-Kitneg cells. Purified donor-derived
CCE-25-Kitneg cell fractions (Ly-5.2) were co-
transplanted with 2 3 105 competing host
BMCs (rotor off [RO] Ly-5.1 cells) into host-
irradiated recipient mice and then monitored
for STRC and LTRC activity, as described in
the Experimental Procedures. The RO cells
represent those bone marrow cells that re-
main after elutriation and contain cells with
both STRC and LTRC activity that is equiva-
lent to normal marrow. These results are rep-
resentative of three separate experiments.
(B) Determination of trilineage donor recon-
stitution of transplanted CCE-25 c-Kitneg cells
by flow cytometry. BMC were harvested from
recipient mice 10±12 months after trans-
plantion with CCE-25 c-Kitneg and RO cells
and incubated with antibodies that recognize
donor cells (Ly-5.2) and GR-1 (granulocytes)
or B220 (B cells). In addition, thymocytes
were harvested from the same mice and la-
beled with antibodies that recognize Ly-5.2
and Thy-1 (T cells). Isotype-matched control
staining of BMC is shown in the upper left
panel, and control staining of thymocytes is
shown in the lower left panel.
these cells would benefit from assays of shorter dura- examine this possibility, donor-derived CCE-25, CCE-
25 c-Kitpos, and CCE-25 c-Kitneg cells were transplantedtion. Therefore, we sought to determine whether these
cells contained pre-CFU-S activity, which could be used into lethally irradiated recipients in pre-CFU-s assays,
and BMCs were harvested from primary and secondaryto further purifiy this cell population (Ploemacher and
Brons, 1988b; Spangrude and Johnson, 1990). CCE-25 recipients 10±12 days after transplantation and then an-
alyzed by two-color flow cytometry for donor-derivedcell fractions were transplanted into lethally irradiated
mouse recipients, and, after 12 days, the spleens were c-Kitpos cells (Ly-5.2 3 c-Kit). Thus far, we have been
unable to detect c-Kitpos cells in the bone marrow ofremoved to determine the number of primary CFU-s
d12, while BMCs from the same mice were transplanted primary recipient mice (data not shown). Furthermore,
as expected, donor-derived c-Kitpos cells were not pres-into secondary irradiated recipients for secondary CFU-s
d12 determinations. As would be predicted from the ent in secondary recipient mice that were transplanted
with bone marrow from saline-treated primary recipientsSTRC results (Table 1), both CCE-25 and the CCE-25
c-Kitpos cells have primary CFU-s d12 activity (Figure (control mice) (Figures 4A and 4B) (isotype-matched
control in Figure 4B was roughly the same for all trans-3A, top row), while the CCE-25 c-Kitneg cells and saline-
transplanted control mice lack primary CFU-s d12 activ- planted mice). In comparison, donor-derived c-Kitpos cells
were detected in secondary recipients transplanted withity (Figures 3A, top row, and 3B). Interestingly, CCE-25
c-Kitneg cells give rise to secondary CFU-s (pre-CFU-s), BMCs from primary recipients that had received donor-
derived CCE-25 cells or CCE-25 c-Kitpos cells (Figureas do the CCE-25 and CCE-25 c-Kitpos cell fractions
(Figures 3A, bottom row, and 3B). Thus, the CCE-25 4A; data not shown). Finally, in mice that had received
donor-derived CCE-25 c-Kitneg cells, roughly 50% of thec-Kitneg population contains cells with pre-CFU-s activity
in addition to LTRC activity that appear to require growth c-Kitpos cell population was of donor origin. Thus, the
transplanted CCE-25 c-Kitneg cells give rise to CCE-25and differentiation signals provided in vivo.
c-Kitpos cells in vivo.
This observation was confirmed in other experimentsCCE-25 c-Kitneg Cells Give Rise to c-Kitpos
Cells In Vivo examining the phenotype of cells isolated from second-
ary CFU-s colonies. Specifically, secondary CFU-s colo-Because cells that express c-Kit are required for defini-
tive hematopoietic development, we speculated that the nies from mice that had received donor-derived CCE-
25 c-Kitneg cells were visually identified and dissectedc-Kitneg cells should give rise to c-Kitpos cells in vivo. To
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Figure 3. Pre-CFU-s Activity of the Fractionated CCE-25 Cell Populations
(A) Photomicrograph of primary and secondary CFU-s colonies. Normal BMC were further purified by CCE and flow cytometry using antibodies
that recognize c-Kit according to the procedures outlined in the Experimental Procedures. The indicated cell populations were transplanted
into lethally irradiated mouse recipients, and spleens were removed after 12 days (Primary CFU-s) and fixed in Bouins solution to visualize
the colonies. BMC from the primary recipients were then transplanted into secondary irradiated mouse recipients, and spleens were removed
after 12 days (secondary CFU-s) and fixed in Telekinizky's solution. The number of cells that were transplanted to produce the primary and
secondary CFU-s colonies shown does not directly correspond with the number of cells that were transplanted in (B), below.
(B) Pre-CFU-s activity of CCE-25 separated cells. BMC populations were administered i.v. to lethally irradiated recipient mice for determination
of pre-CFU-s activity. The number of pre-CFU-s was determined by the following formula also described in the Experimental Procedures:
number of secondary CFU-s X (number of BMCs per femur in the primary recipient after 12 days/number of cells transplanted into the secondary
recipient)/number of cells transplanted in the primary recipient. These results are representative of at least three separate experiments.
from freshly harvested spleens. Single-cell suspensions Cell Surface Phenotype of CCE-25 c-Kitneg Cells
To determine the cell surface phenotype of the CCE-25were obtained from these secondary CFU-s colonies
and then stained with antibodies that recognize donor c-Kitneg cells, we first examined the freshly elutriated
CCE-25 cells for the expression of lineage-specific cellcells (Ly-5.2) and c-Kit. We found that all of the colonies
examined contained cells of donor origin (Ly-5.2) and surface antigens using antibodies and flow cytometry.
In these preliminary experiments, the CCE-25 lackedthat some of these cells coexpressed c-Kit (Figure 4C).
However, not all of the cells within each colony were of the expression of GR-1 (granulocytes), Mac-1, and F4/
80 (macrophage) antigens, while 30% of the cells ex-donor origin. In this regard, it is likely that the other cells
are recipient splenocytes obtained as a result of the pressed TER-119 (erythroid) and 50% expressed B220
or CD-19 (B cell) antigens (data not shown). Thus, CCE-dissection of the secondary CFU-s or are erythroid cells
that do not express Ly-5 antigens (we observed morpho- 25 cells do not contain granulocytes or macrophages
but contain populations of erythroid and B cells (TER-logically identifiable erythroid cells in cytospins of sec-
ondary CFU-s colonies; data not shown). Finally, we 119 and B220/CD-19 antigens were not coexpressed).
Next, to further define the phenotype of the CCE-25FACS separated the Ly-5.21c-Kit1 cells from secondary
CFU-s colonies of mice that had received donor-derived c-Kitneg cells, we stained the CCE-25 cells with antibod-
ies that recognize c-Kit labeled with phycoerythrinCCE-25 c-Kitneg cells using the gate shown in Figure 4C
(R1) to determine their function in vivo. We were able (c-Kit-PE) and antibodies that recognize B220 and Ter-
119 labled with allophycocyanin (B220/TER-APC) (Fig-to radioprotect (STRC activity) 3 out of 5 recipient mice
when transplanting 2 3 104 Ly-5.21c-Kit1 cells and 4 ure 5B). As described for Figure 1, a sort gate was set
around the CCE-25 cells using forward and side scatterout of 5 mice when transplanting 5 3 104 Ly-5.21c-Kit1
cells, but we did not radioprotect at doses below 2 3 light profiles (Figure 5A, R1), and then a sort gate was
set around the c-Kitneg B220neg Ter-119neg CCE-25 cells104 Ly-5.21c-Kit1 cells (data not shown). Analysis of
bone marrow cells and thymocytes obtained from the (Figure 5A, R2). We purified the c-KitnegB220negTer-119neg
cell population by FACS (Figure 5C) (roughly 1%±5% ofsurviving mice after 4 months showed trilineage donor
reconstitution (data not shown). the starting CCE-25) and determined that this population
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Figure 4. Detection of c-Kitpos Cells in the Bone Marrow and Spleen of Secondary Recipient Mice Transplanted with c-Kit FACS-Sorted CCE-
25 Cell Fractions
(A) The percentage of donor-derived c-Kitpos cells in the bone marrow of secondary recipient mice. CCE-25 (2 3 105 cells), CCE-25-c-Kitneg
(2 3 105 cells), and CCE-25-c-Kitpos (5 3 104 cells) cell fractions (Ly-5.2) were transplanted into lethally irradiated primary recipients (Ly-5.1),
and after 12 days the bone marrow was removed and then transplanted into lethally irradiated secondary recipients (Ly-5.1) according to the
procedures described in the Experimental Procedures. Bone marrow was obtained from the secondary recipients 12 days after transplantation
and analyzed for donor cells that express c-Kit by flow cytometry.
(B) Detection of donor-derived c-Kitpos cells in the bone marrow of secondary recipients by flow cytometry. CCE-25 cells, CCE-25 c-Kitneg
cells, and saline (control) were transplanted into irradiated recipient mice in pre-CFU-s assays according to the procedures outlined in the
Experimental Procedures. Bone marrow was obtained from the secondary recipients 10±12 days after transplantation and analyzed for donor
cells (Ly-5.2) that express c-Kit by two-color FACS analysis. The isotype-matched control staining shown in the left panel was roughly the
same in all transplanted mice.
(C) Presence of donor-derived c-Kitpos cells in secondary CFU-s d12 colonies. CCE-25 c-Kitneg cells were transplanted in pre-CFU-s assays,
and individual CFU-s d12 colonies were dissected from spleens to obtain single-cell suspensions. The cells were analyzed for donor cells
(Ly-5.2) that express c-Kit by two-color FACS analysis, and the results of two separate colonies are shown (second and third panel from the
left). FACS analysis of the isotype-matched control staining for one colony is shown in the left staining panel (control is the same for the other
colony; data not shown).
contained all of the detectable pre-CFU-s activity and Thus, similar to other primitive progenitor populations,
the c-KitnegB220negTer-119neg CCE-25 cell population isLTRC activity (in competitive repopulation assays), while
the c-KitnegB220posTer-119pos CCE-25 cell population had heterogeneous with respect to the expression of other
cell surface antigens that could be employed to furthernone of these activities (data not shown). Finally, we
further defined the phenotype of the c-KitnegB220negTer- purify this cell population.
To determine the cell cycle status of the CCE-25 cell119neg CCE-25 cells by three-color FACS analysis using
antibodies labeled with a third color (FITC). Comparing populations, we labeled normal BMC, CCE-25 cells, and
CCE-25 c-Kitneg cells with propidium iodide. These cellthe expression of other antigens present on primitive
progenitor cell populations, we found that roughly 22% populations were then analyzed with a coulter profile
FACS machine, and the percentage of cells in cycle wasof the c-KitnegB220negTer-119neg CCE-25 cells expressed
Sca-1 (Figure 5D), 30% expressed CD-34 and Thy-1 (dull determined using Multiplus by Phonix Flow System. In
agreement with previous data, roughly 28% of the nor-expression) (Figures 5E and 5F), and 20% expressed
CD-4 (Figure 5I), while they lacked expression of FLT-3 mal BMC population is in S or G2/M (Figure 5M). In
comparison, only 2% of the unfractionated CCE-25 cellsand IL-6a receptors (Figures 5G and 5H). In addition, the
c-KitnegB220negTer-119neg CCE-25 cells also expressed are in S or G2/M (Figure 5N), and .99% of the c-Kitneg
CCE-25 cells were in G1/G0 (Figure 5O). Thus, the c-KitnegCD-38 (Figure 5J), (present on more committed progeni-
tors), CD-43 (leukosialin), and CD-24 (heat-stable anti- CCE-25 cells are highly enriched for quiescent cells
(G1/G0).gen) (Figures 5K and 5L), which are involved in adhesion.
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Figure 5. Cell Surface Phenotype of CCE-25
c-Kitneg Cells
CCE-25 cells were analyzed by three-color
flow cytometry by gating CCE-25 cells by size
([A] R1) and then for cells that did not express
c-Kit and B220/TER-119 ([B] R2). This popu-
lation was either sorted ([C] R4) or further
analyzed using antibodies labeled with the
third color, FITC ([D±L] as indicated). Finally,
BMC (M), CCE-25 cells (N), and CCE-25
c-Kitneg cells (O) were labeled with propidium
iodide (PI) and analyzed for the percent cells
in cycle.
Discussion (Ogawa et al., 1991; Okada et al., 1991, 1993; Orlic et
al., 1993; Chung and Johnson, 1995). It is also for this
reason that we are unable to calculate repopulating unitsWe have been able to physically and functionally sepa-
rate two classes of PHSCs within the small cell size (quantitate stem cell activity) by Harrison's methods,
since this model assumes that competing PHSC popula-fraction of bone marrow. First, the CCE-25 c-Kitpos
PHSCs that are functionally similar to previously de- tions contribute equally to repopulation (Harrison et al.,
1990). Alternatively, the delayed reconstitution/recruit-scribed c-Kitpos PHSCs, which proliferate in response to
combinations of HGFs in vitro, and have STRC, CFU-s ment kinetics of the c-Kitneg cells could be explained
by competition with host/endogenous c-Kitneg PHSCs,d12, and LTRC activity when transplanted in vivo. In
comparison, the CCE-25 c-Kitneg cells represent a more which survive irradiation and could represent a signifi-
cant competing PHSC population.primitive class of PHSCs that do not proliferate in re-
sponse to HGFs in vitro, have no STRC or CFU-s d12 We are also unable to explain why donor-derived
c-Kitneg cells give rise to c-Kitpos cells in the secondaryactivity, and yet have delayed LTRC and pre-CFU-s ac-
tivity in vivo. Furthermore, the CCE-25 c-Kitneg cells give transplanted recipients after 2±3 weeks in pre-CFU-s
assays, yet show delayed engraftment (10±12 months)rise to c-Kitpos cells in vivo in pre-CFU-s assays, support-
ing the hypothesis that c-Kitpos cells can be recruited in competitive repopulation assays. However, we feel
this can be explained, in part, by differences in the twofrom c-Kitneg cells.
While we are unable to explain why CCE-25 c-Kitneg in vivo assay systems. For example, in the pre-CFU-s
assay, the c-Kitneg cells are transplanted without radio-cells show delayed (10±12 months) reconstitution/recruit-
ment kinetics when transplanted in competitive repopu- protective cells and, therefore, are not in competition
with cotransplanted c-Kitpos PHSCs. Furthermore, thelation assays, it is likely that the c-Kitpos PHSCs present
in the cotransplanted bone marrow cell population dom- sequential transplantation of the c-Kitneg cells into pri-
mary and secondary irradiated recipients in pre-CFU-sinate hematopoietic reconstitution over the first 4±6
months after transplantation, since these cells have assays exposes these cells twice to the conditions/
microenvironment of an irradiated host, which mightbeen shown to be rapidly repopulating PHSCs (Table 1)
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Figure 6. Summary of c-Kit Maturation Pathway
This summary depicts dormant CCE-25 cells
(left) that lack c-Kit mRNA expression and cell
surface protein expression that give rise to
c-Kit,low PHSCs, which express c-kit mRNA
yet lack cell surface c-Kit expression. The
c-Kit,low PHSCs differentiate into previously
characterized PHSC populations that ex-
press both c-kit mRNA and c-Kit cell surface
protein (also express Sca-1) and represent
an actively contributing stem cell population.
Finally, c-Kitpos PHSCs further differentiate to
give rise to the various committed progenitor
cell populations.
better promote their growth and differentiation into cells are similar to the recently discovered ªmysteryº
BMC population, which has the cell surface phenotypec-Kitpos PHSCs. In this regard, we do not know if all
or some of the transplanted CCE-25 c-Kitneg cells are of previously characterized PHSCs yet lacks c-Kit ex-
pression, CFU-s, CFU-c, STRC, and functional PHSCrecruited into the c-Kitpos cell pool and what signals
(HGFs/microenvironment) are required for the induction activity; however, donor reconstitution of this cell popu-
lation was not assessed at 10 months or longer (Randallof c-Kit expression in these cells. To begin to character-
ize the signals required to recruit dormant c-Kitneg PHSCs and Weissman, 1997). The CCE-25 c-Kitneg cells may
also be related to a recently identified ªc-Kit,lowº PHSCand what mechanisms regulate PHSC survival/prolifera-
tion/self renewal, future studies will examine (1) the abil- that does not express cell surface c-Kit, yet expresses
c-Kit mRNA by RT±PCR (Doi et al., 1997) (Figure 6). Itity of CCE-25 c-Kitneg cells to produce cobblestone colo-
nies and/or hematopoietic progenitors when cultured is interesting to speculate that the c-Kit,low cells (c-Kit
mRNApos and cell surface c-Kitneg), which were purifiedon normal hematopoietic stroma or stromal cell lines in
vitro, (2) whether c-Kit expression can be induced on from the BM of mice 4 days after 5-FU injection, could
represent a ªtransitionalº PHSC population that are de-c-Kitneg cells in vitro, and (3) whether actively contributing
c-Kitpos PHSCs can lose the expression of c-Kit and rived from the CCE-25 c-Kitneg cells (c-Kit mRNAneg and
cell surface c-Kitneg) (summarized in Figure 6). Accordingbecome quiescent or dormant stem cells.
Because c-Kitpos cells are readily detected in CFU-c, to this maturation pathway, the c-Kit,low cell population
would further differentiate into c-Kitpos PHSCs (c-KitSTRC, and CFU-s d12 assays at very low cell numbers
(Ogawa et al., 1991; Okada et al., 1991, 1993; Katayama mRNApos and c-Kit cell surface expressionpos). The
c-Kitpos PHSC has been shown to coexpress Sca-1 anti-et al., 1993; Orlic et al., 1993; Osawa et al., 1996; Chung
and Johnson, 1995; Uchida et al., 1998), we feel that the gen and has been further fractionated and purified using
other markers that include CD-34, Rhd, and IL-7 (Span-absence of detectable c-Kit mRNA by RT±PCR and the
lack of detectable CFU-c, STRC, and CFU-s d12 activi- grude et al., 1991; Chung and Johnson, 1995; Osawa et
al., 1996; Kondo et al., 1997). The c-Kitpos PHSCs furtherties in the CCE-25 c-Kitneg cell population, especially
when using high cell numbers in these assays, support differentiate and lose the expression of Sca-1 and c-Kit
in the majority of committed cell progeny (Figure 6).the notion that the CCE-25 c-Kitneg cells are not contami-
nated with c-Kitpos PHSCs. For example, we would have Finally, the CCE-25 c-Kitneg cells may also be related to
a PHSC isolated by Jones et al. that lacks cell surfaceexpected to see some level (1%±5%) of donor reconsti-
tution in competitive repopulating assays after 4±6 AA4.1 antigen expression and expresses aldehyde de-
hydrogenase activity; however, unlike the CCE-25 c-Kitnegmonths if the CCE-25-c-Kitneg population contained
c-Kitpos cells, or we would have detected some radiopro- cells, these PHSCs show donor reconstitution after 2
months when transplantated with radioprotective cellstective/LTRC activity when transplanting up to 5 3 106
CCE-25 c-Kitneg cells alone (Figure 2), especially since in vivo (earlier time points were not examined) (Jones
et al., 1996). In addition, insufficient numbers (1,000 andit has been shown that ªsingleº isolated c-Kitpos PHSCs
can be readily detected after 4±6 months in competitive 10,000) of this PHSC population were transplanted in
vivo to determine whether they completely lacked CFU-srepopulation assays, and very few are required to pro-
vide radioprotection to irradiated recipients (Osawa et d12 and STRC activity.
In summary, we feel that c-Kitpos PHSCs can ariseal., 1996; Uchida et al., 1998). Finally, we have not de-
tected c-Kitpos cell contamination in experiments where from a dormant/quiescent population of c-Kitneg PHSCs
(.99% in G0/G1 by propidium iodide staining) by mecha-we have further purified the CCE-25 c-Kitneg cells by
flow cytometry using antibodies that recognize other nisms that remain to be determined. Whether this c-Kit
maturation process is also important or significant incell surface antigens (e.g., Sca-1, B220, and Ter-119) in
the pre-CFU-s assay (data not shown). primitive hematopoietic development remains to be elu-
cidated. Also, this developmental process may be re-With regard to previously characterized PHSC popula-
tions, it is tempting to speculate that the CCE-25 c-Kitneg flected in other tissues because c-Kit is expressed on
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were incubated in a fully humidified atmosphere at 378C, 5% CO2,progenitor/stem cells found in the liver, skin, gut, brain,
and then scored for colony formation after 7±10 days (colony-form-and gonads (Blouin and Bernstein, 1993; Broudy, 1997).
ing unit-culture, CFU-c).Therefore, further purification and study of the mecha-
nisms that regulate survival, proliferation, differentiation,
Bone Marrow Transplantation and Assays for Short-Termand c-Kit expression of CCE-25 c-Kitneg cells may add
and Long-Term Hematopoietic Reconstitutiongreatly to our understanding of stem cell biology.
C57BL/6 (Ly-5.1) recipient mice were exposed to 10 Gy total body
lethal irradiation (137Cesium irradiation) 3 hr prior to the i.v. injection
Experimental Procedures BMC. STRC activity is defined as those cell populations that allow
the survival of lethally irradiated mice for 40±60 days. To determine
Mice LTRC activity, BMCs and thymocytes were harvested from recipient
C57BL/6 (Ly-5.2) and congenic C57BL/6 (Ly-5.1) mice 8±12 weeks of mice 4±6 months or longer after transplantation for FACS analysis.
age were obtained from the animal production area at the Frederick Hematopoietic reconstitution of donor and host (recipient) cells was
Cancer Research and Development Center (Frederick, MD). Animal determined by two-color FACS analysis using monoclonal antibod-
care was provided in accordance with the procedures outlined in ies A-20±1.7 (recognizes host-derived Ly-5.11 cells) and 104±2.1
the ªGuide for Care and Use of Laboratory Animalsº (publication (recognizes donor-derived Ly-5.21 cells) or isotype-matched control
number 86±23, Bethesda, MD, National Institutes of Health, 1985). antibodies that were developed with FITC-conjugated affinity-puri-
Mice were maintained in a pathogen-free environment. fied goat anti-mouse IgG2a (Southern Biotech). To determine the
percentage of lineage-specific cells of host or donor origin, B cells
Bone Marrow Separation and granulocytes in the bone marrow were also stained with biotin-
BMCs were aspirated from the femurs of mice with complete Is- conjugated RA3±6B2 (B220) or biotin-conjugated RB6±8C5, respec-
cove's modified Dulbecco's medium (IMDM) (GIBCO) containing tively (Pharmingen), or isotype-matched control antibodies and de-
10% FCS, 3 mg/ml glutamine, and antibiotics. Cells were further veloped with SA-PE (Southern Biotech). Flow cytometry gates were
purified by CCE. Briefly, 0.5 to 1 3 108 BMCs in 10±20 ml complete set around the total cell population as well as the B cell and granulo-
IMDM were elutriated using a Beckman J-6M centrifuge with a cyte windows using side and forward light scatter profiles. To deter-
JE26B elutriator rotor and a standard chamber at a flow rate of 15 mine the percentage of T cells in the thymus, cells were also stained
ml per min at 3,000 rpms. The flow rate was then adjusted to 25 ml with biotin-conjugated anti-Thy-1 (Pharmingen) or isotype-matched
per min, and 300 ml containing cells was recovered (CCE-25). The control antibodies and developed with SA-PE. The level of donor
rotor off fraction contains the remaining BMC populations. The CCE- reconstitution for each lineage was averaged plus or minus standard
25 cells were further purified by flow cytometry using biotin labeled error for each group consisting of at least 3±5 mice.
anti-c-Kit or isotype-matched control antibodies (Pharmingen) at 1 To determine the pre-CFU-s content of the various BMC fractions,
mg/1 3 106 cells/100 ml of medium for 30 min at 48C. The cells were the spleen was removed from primary transplanted recipients after
washed in HBSS containing 0.02% BSA, resuspended in the same 12 days to enumerate colonies on the spleen (primary CFU-s d12).
medium, and then stained with 1 mg of Neutrilite Avidin-PE (SA-PE) Bone marrow was aspirated from the same group of mice, pooled,
(Southern Biotech) for 2 3 107 cells/ml for 30 min at 48C. The cells and then transplanted into a secondary irradiated recipient. The
were washed and resuspended in the same medium to approxi- spleens from the secondary recipients were removed to determine
mately 1 3 107 cells/ml for FACS sorting (Becton Dickinson). For the number of secondary CFU-s d12. The number of preCFU-s was
phenotype analysis, CCE-25 cells were incubated with PE-labeled determined by the following formula: number of secondary CFU-s 3
c-Kit, APC-labeled B220 and Ter-119, or FITC-labeled Sca-1, CD- (number of BMCs per femur in the primary recipient after 12 days/
34, Thy-1, CD-38, CD-43, CD-24, CD-126 (IL-6Ra), CD-4 (purchased number of cells transplanted into the secondary recipient)/number
from Pharmingen) at 1 mg/1 3 106 cells/100 ml of medium for 30 min of cells transplanted in the primary recipient.
at 48C. The cells were washed in HBSS containing 0.02% BSA and
then resuspended in the same medium for FACS analysis.
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